Skip to search formSkip to main contentSkip to account menu

ocular hypotensive

Known as: antiglaucoma drug 
National Institutes of Health

Related topics

Related topics

3 relations

Narrower (1)

Colforsin
Glaucoma

Broader (1)

OPHTHALMIC AGENTS

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2020
2020
Effect of trabeculectomy and Ahmed glaucoma valve implantation surgery on corneal biomechanical changes
Purpose To evaluate alterations in corneal biomechanical properties before and 6 months after conventional trabeculectomy (TRAB… 
2014
2014
Multidisciplinary Ophthalmic Imaging In Vivo Assessment of Aqueous Humor Dynamics Upon Chronic Ocular Hypertension and Hypotensive Drug Treatment Using Gadolinium-Enhanced MRI
NeuroImaging Laboratory, University of Pittsburgh, Pittsburgh, Pennsylvania, United States UPMC Eye Center, Eye and Ear Institute… 
2014
2014
Comparison of corneal safety and intraocular pressure-lowering effect of tafluprost ophthalmic solution with other prostaglandin ophthalmic solutions.
PURPOSE The benzalkonium chloride (BAK) content of tafluprost ophthalmic solution (Tapros(®): tafluprost) has been reduced to… 
2010
2010
Pilocarpine Protects Cobalt Chloride-induced Apoptosis of RGC-5 Cells: Involvement of Muscarinic Receptors and HIF-1α Pathway
The retina is the most metabolically active tissue in the human body and hypoxia-induced retinal ganglion cell (RGC) death has… 
2009
2009
Antiglaucoma drug GLC756 and its effect on cellular cAMP and tumor necrosis factor α release in vitro of activated human monocytic leukemia cells
PurposeGLC756, a putative antiglaucoma drug with dopamine D2 agonist and D1 antagonist properties, significantly decreases tumor… 
2006
2006
Effects of Antiglaucoma Drugs GLC756, a Novel Dopamine D2 Agonist and D1 Antagonist, and Timolol on Endotoxin-Induced TNF-Alpha Release in Serum of Rats
Purpose Anti-inflammatory activity of an antiglaucoma drug may be an advantage for long-term treatment of glaucoma since it may… 
2000
2000
Effects of topical nipradilol, a beta blocking agent with alpha blocking and nitroglycerin-like activities, on intraocular pressure and aqueous dynamics in humans.
AIMS To study the effects of topical nipradilol, a non-selective beta blocker with alpha blocking and nitroglycerin-like… 
1999
1999
[The evaluation of morphological status of bulbar conjunctiva after long-term antiglaucoma drug therapy].
UNLABELLED The aim of this study was to examine the histopathologic picture of bulbar conjunctiva in glaucoma patients receiving… 
1997
1997
Hornhautsensibilitätsveränderung nach topischer Dorzolamidapplikation Vergleichende Studie
Background: The new antiglaucoma drug, dorzolamide, mainly evokes local side effects like eye burning, pruritus, blurred sight… 
1995
1995
Minimal cardiac electro-physiological activity of alprenoxime, a site-activated ocular β-blocker, in dogs
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)